FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2918453079> ?p ?o ?g. }

• W2918453079 endingPage "690" @default.
• W2918453079 startingPage "679" @default.
• W2918453079 abstract "Acute myeloid leukaemia (AML) is a lethal haematological malignancy characterized by an immunosuppressive milieu in the tumour microenvironment (TME) that fosters disease growth and therapeutic resistance. Hypomethylating agents (HMAs) demonstrate clinical efficacy in AML patients and exert immunomodulatory activities. In the present study, we show that guadecitabine augments both antigen processing and presentation, resulting in increased AML susceptibility to T cell-mediated killing. Exposure to HMA results in the activation of the endogenous retroviral pathway with concomitant downstream amplification of critical mediators of inflammation. In an immunocompetent murine leukaemia model, guadecitabine negatively regulates inhibitory accessory cells in the TME by decreasing PD-1 (also termed PDCD1) expressing T cells and reducing AML-mediated expansion of myeloid-derived suppressor cells. Therapy with guadecitabine results in enhanced leukaemia-specific immunity, as manifested by increased CD4 and CD8 cells targeting syngeneic leukaemia cells. We have previously reported that vaccination with AML/dendritic cell fusions elicits the expansion of leukaemia-specific T cells and protects against disease relapse. In the present study, we demonstrate that vaccination in conjunction with HMA therapy results in enhanced anti-leukaemia immunity and survival. The combination of a novel personalized dendritic cell/AML fusion vaccine and an HMA has therapeutic potential, and a clinical trial investigating this combination is planned." @default.
• W2918453079 created "2019-03-11" @default.
• W2918453079 creator A5002386517 @default.
• W2918453079 creator A5009061331 @default.
• W2918453079 creator A5013989133 @default.
• W2918453079 creator A5020529918 @default.
• W2918453079 creator A5031452560 @default.
• W2918453079 creator A5037637724 @default.
• W2918453079 creator A5038581738 @default.
• W2918453079 creator A5042143959 @default.
• W2918453079 creator A5047806967 @default.
• W2918453079 creator A5052641327 @default.
• W2918453079 creator A5054346063 @default.
• W2918453079 creator A5055553389 @default.
• W2918453079 creator A5058899283 @default.
• W2918453079 creator A5067054634 @default.
• W2918453079 creator A5067994799 @default.
• W2918453079 creator A5071858483 @default.
• W2918453079 creator A5076036129 @default.
• W2918453079 creator A5080905302 @default.
• W2918453079 creator A5080982554 @default.
• W2918453079 creator A5088062204 @default.
• W2918453079 creator A5091120493 @default.
• W2918453079 date "2019-03-03" @default.
• W2918453079 modified "2023-10-11" @default.
• W2918453079 title "Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine" @default.
• W2918453079 cites W1503744211 @default.
• W2918453079 cites W1533305218 @default.
• W2918453079 cites W1827923022 @default.
• W2918453079 cites W1855418724 @default.
• W2918453079 cites W1905278501 @default.
• W2918453079 cites W1953890763 @default.
• W2918453079 cites W1968821227 @default.
• W2918453079 cites W1982035148 @default.
• W2918453079 cites W1983279230 @default.
• W2918453079 cites W1983973479 @default.
• W2918453079 cites W1985182657 @default.
• W2918453079 cites W1986388364 @default.
• W2918453079 cites W1986769067 @default.
• W2918453079 cites W1996972360 @default.
• W2918453079 cites W2000715091 @default.
• W2918453079 cites W2004150448 @default.
• W2918453079 cites W2021732286 @default.
• W2918453079 cites W2026782606 @default.
• W2918453079 cites W2027155762 @default.
• W2918453079 cites W2031006855 @default.
• W2918453079 cites W2035046853 @default.
• W2918453079 cites W2042185775 @default.
• W2918453079 cites W2060070314 @default.
• W2918453079 cites W2075440816 @default.
• W2918453079 cites W2077778517 @default.
• W2918453079 cites W2089717366 @default.
• W2918453079 cites W2093144236 @default.
• W2918453079 cites W2098337213 @default.
• W2918453079 cites W2106082819 @default.
• W2918453079 cites W2106084333 @default.
• W2918453079 cites W2115764350 @default.
• W2918453079 cites W2116858301 @default.
• W2918453079 cites W2125882975 @default.
• W2918453079 cites W2135908778 @default.
• W2918453079 cites W2141476381 @default.
• W2918453079 cites W2147210428 @default.
• W2918453079 cites W2160666689 @default.
• W2918453079 cites W2342445623 @default.
• W2918453079 cites W2384094940 @default.
• W2918453079 cites W2560536699 @default.
• W2918453079 cites W2601669236 @default.
• W2918453079 cites W2784179963 @default.
• W2918453079 cites W2807921312 @default.
• W2918453079 doi "https://doi.org/10.1111/bjh.15818" @default.
• W2918453079 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6590084" @default.
• W2918453079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30828801" @default.
• W2918453079 hasPublicationYear "2019" @default.
• W2918453079 type Work @default.
• W2918453079 sameAs 2918453079 @default.
• W2918453079 citedByCount "43" @default.
• W2918453079 countsByYear W29184530792019 @default.
• W2918453079 countsByYear W29184530792020 @default.
• W2918453079 countsByYear W29184530792021 @default.
• W2918453079 countsByYear W29184530792022 @default.
• W2918453079 countsByYear W29184530792023 @default.
• W2918453079 crossrefType "journal-article" @default.
• W2918453079 hasAuthorship W2918453079A5002386517 @default.
• W2918453079 hasAuthorship W2918453079A5009061331 @default.
• W2918453079 hasAuthorship W2918453079A5013989133 @default.
• W2918453079 hasAuthorship W2918453079A5020529918 @default.
• W2918453079 hasAuthorship W2918453079A5031452560 @default.
• W2918453079 hasAuthorship W2918453079A5037637724 @default.
• W2918453079 hasAuthorship W2918453079A5038581738 @default.
• W2918453079 hasAuthorship W2918453079A5042143959 @default.
• W2918453079 hasAuthorship W2918453079A5047806967 @default.
• W2918453079 hasAuthorship W2918453079A5052641327 @default.
• W2918453079 hasAuthorship W2918453079A5054346063 @default.
• W2918453079 hasAuthorship W2918453079A5055553389 @default.
• W2918453079 hasAuthorship W2918453079A5058899283 @default.
• W2918453079 hasAuthorship W2918453079A5067054634 @default.
• W2918453079 hasAuthorship W2918453079A5067994799 @default.
• W2918453079 hasAuthorship W2918453079A5071858483 @default.

• next